clarithromycin has been researched along with Diabetes Mellitus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, K; Imai, G; Kojima, M; Ooi, A; Takemori, N | 1 |
| Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, AYS; Wong, ICK | 1 |
| Chornyy, V; Kazory, A; Koratala, A | 1 |
3 other study(ies) available for clarithromycin and Diabetes Mellitus
| Article | Year |
|---|---|
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clarithromycin; Diabetes Mellitus; Female; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Thalidomide; Treatment Outcome | 2018 |
Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.
Topics: Aged; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Cohort Studies; Diabetes Mellitus; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Propensity Score; Proportional Hazards Models; Risk Factors; Stomach Neoplasms; Time Factors | 2019 |
Exit Site Infection in Peritoneal Dialysis; Need for Follow-Up on Cultures Despite Clinical Improvement.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacterial Typing Techniques; Clarithromycin; Diabetes Mellitus; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis; Surgical Wound Infection | 2017 |